Stepan Eyes Margin Recovery as Catalyst Targets $100M in Savings
Stepan NYSE: SCL is in the early stages of a margin recovery, supported by growth in higher-margin product areas, cost reductions and broader-based volume gains, Chief Financial Officer Ruben Velasquez said during a company presentation.
Stepan Q2 Earnings Call Highlights
Stepan NYSE: SCL reported higher second-quarter earnings as broad-based volume growth, margin recovery and early savings from its Project Catalyst program lifted results, while management cautioned that some demand may have been pulled forward amid geopolitical and raw-material uncertainty.
Stepan Co. (SCL) Surpasses Q2 Earnings and Revenue Estimates
Stepan Co. (SCL) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.52 per share a year ago.
Stepan Company's Discount Isn't Over Yet
Stepan Company remains a 'buy' due to attractive valuation, despite recent underperformance versus the S&P 500. Recent results show mixed fundamentals: revenue growth driven by Surfactants, but profitability pressured by restructuring charges and raw material costs. Project Catalyst targets $100 million in pre-tax cost savings over two years, with 60% expected this year and the remainder next.
Stepan Company (SCL) Q1 2026 Earnings Call Transcript
Stepan Company (SCL) Q1 2026 Earnings Call Transcript
Stepan Co. (SCL) Beats Q1 Earnings Estimates
Stepan Co. (SCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.84 per share a year ago.
Earnings Preview: Stepan Co. (SCL) Q1 Earnings Expected to Decline
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Company: The Ride Higher Isn't Over Yet
Stepan Company (SCL) is reaffirmed as a 'buy' due to compelling valuation and significant cost-saving initiatives. SCL's Project Catalyst targets $100M in pre-tax savings over two years, with 60% expected in the current year. Despite mixed profitability and cash flow, SCL remains attractively priced versus peers, especially on cash flow metrics.
Stepan Company: Upside Unclear, Better Alternatives Exist
Stepan Company remains a 'BUY' with a lowered fair value estimate of $85/share and a price target of $71/share, reflecting increased market uncertainty. SCL's 2025 results show early signs of operational recovery—6% EBITDA growth, reduced net debt, and positive FCF in 4Q25—driven by asset rationalization and cost savings. 2026E forecasts nearly double AEPS versus 2025, with 47% growth expected, but much of this upside appears priced in after the recent share price surge.
Stepan Company (SCL) Q4 2025 Earnings Call Transcript
Stepan Company (SCL) Q4 2025 Earnings Call Transcript
Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates
Stepan Co. (SCL) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.35. This compares to earnings of $0.12 per share a year ago.
Stepan Continues Footprint Optimization Through LA Asset Sale
SCL advances footprint optimization with the sale of Lake Providence, LA assets, following its SPQI divestiture to sharpen focus on core growth.
